Trial Information
Inclusion Criteria:
- age 18-40 yr,
- metformin treatment for at least 3 months before entering the pregnancy,
- gestational age between 5 and 12 wk
Exclusion Criteria:
- diabetes mellitus
- significant liver or renal impairment
- neoplasms and other endocrine diseases
- the use of drugs other than metformin able to interfere with glucose and insulin
metabolism.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
incidence of gestational diabetes
Authority:
Italy:Catholic University of Sacred Heart
Study ID:
000082011
NCT ID:
NCT01594697
Start Date:
Completion Date:
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome